Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[I]iodo-phenylalanine

Nuclear Medicine Communications

Volumn 28, Issue 10, 2007, Pages 823-828

  Bauwens, Matthias ^a   Keyaerts, Marleen ^a   Lahoutte, Tony ^a   Kersemans, Ken ^a   Caveliers, Vicky ^a   Bossuyt, Axel ^a   Mertens, John ^b  

^a BEFY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Biodistribution; D amino acids; Dosimetry; Healthy volunteers; Iodinated amino acids

Indexed keywords

2 IODO DEXTRO PHENYLALANINE I 123; 2 IODOPHENYLALANINE I 123; TRACER; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSIMETRY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG UPTAKE; ENANTIOMER; HEART; HUMAN; HUMAN EXPERIMENT; KIDNEY ADENOMA; LIVER; MALE; MUSCLE; NORMAL HUMAN; ORGAN DISTRIBUTION; PLASMA CLEARANCE; RADIATION DOSE; URINALYSIS; VOLUNTEER; WHOLE BODY SCINTISCANNING;

ADULT; HUMANS; ISOMERISM; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; PHENYLALANINE; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION; WHOLE-BODY COUNTING;

EID: 34548305098     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282e7d731     Document Type: Article

References (25)

1. Yanagida O, Kanai Y. Human L-type amino acid transport system 1 (LAT1): characterisation of function and expression in tumour cell lines. Biochim Biophys Acta 2001; 1514:291-302.
2. +-independent neutral L-amino acid transporter with broad substrate selectivity. J Biol Chem 1999; 274:19745-19751.
3. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterisation of a transporters for large neutral amino acids activated by heavy chain 4F2 antigen (CD98). J Biol Chem 1998; 273:23629-23632.
4. Campbell WA, Thompson NL. Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts. J Biol Chem 2001; 276:16877-16884.
5. Kim do K, Kanai Y, Choi HW, Tangtrongsup S, Chairoungdua A, Babu E, et al. Characterization of the L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta 2002; 1565:112-121.
6. Kupczyk-Subotkowska L, Tamura K, Pal D, Sakaeda T, Siahaan TJ, Stella VJ, Borchardt RT, et al. Derivatives of melphalan designed to enhance drug accumulation in cancer cells. J Drug Target 1997; 4:359-370.
7. Rajan DP, Kekuda R, Huang W, Devoe LD, Leibach FH, Prasad PD, Ganapathy V. Cloning and functional characterisation of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine. Biochim Biophys Acta 2000; 1463:6-14.
8. Dethy S, Goldman S, Blecic S, Luxen A, Levivier M, Hildebrand J. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med 1994; 35:1162-1166.
9. Ogawa T, Hatazawa J, Inugami A, Murakami M, Fujita H, Shimosegawa E, et al. Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma. J Nucl Med 1995; 36:2175-2179.
10. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, et al. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 1996; 23:1345-1353.
11. 99mTc-HMPAO SPECT. Ann Nucl Med 2002; 16:207-211.
12. Sasaki M, Ichiya Y, Kuwabara Y, Yoshida T, Inoue T, Morioka T, et al. Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity. J Nucl Med 1996; 37:1174-1176.
13. Lahoutte T, Mertens J, Caveliers V, Franken PR, Everaert H, Bossuyt A. Comparative biodistribution of iodinated amino acids: Selection of the optimal analog for oncologic imaging outside the brain. J Nucl Med 2003; 44:1489-1494.
14. Keyaerts M, Lahoutte T, Neyns B, Caveliers V, Vanhove C, Everaert H, et al. (123)I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients. Eur J Nucl Med Mol Imaging 2007; 34:994-1002.
15. 11C-methionine. J Nucl Med 2006; 47:679-688.
16. 18F-fluoropropyl tyrosine as tumour imaging agents in mice. Eur J Nucl Med 2006; 33:1017-1024.
17. 123I-2-iodo-D-phenylalanine, a new potential tumour-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model. J Nucl Med 2005; 46:2104-2111.
18. 125I]-2-iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT. Nucl Med Biol 2004; 31:739-746.
19. 123I-iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2002; 29:625-631.
20. 18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 1999; 40:1367-1373.
21. Rau FC, Weber WA, Wester HJ, Herz M, Becker I, Kruger A, et al. O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med 2002; 29:1039-1046.
22. 18F-FET) uptake in mouse thymoma cells, and its biodistribution in mice and human volunteers. Acta Radiol 2006; 47:1042-1048.
23. 11C-methionine uptake to the pancreas and its secretion: a positron emission tomography study in humans. Pancreas 1999; 18:392-398.
24. 18F-FDG. J Nucl Med 2003; 44:533-539.
25. 123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice. Eur J Nucl Med Mol Imaging 2006; 33:919-927.